159 related articles for article (PubMed ID: 33603611)
1. Periocular basal cell carcinoma: recurrence risk factors/when to reoperate?
Gąsiorowski K; Iwulska K; Zapała J; Wyszyńska-Pawelec G
Postepy Dermatol Alergol; 2020 Dec; 37(6):927-931. PubMed ID: 33603611
[TBL] [Abstract][Full Text] [Related]
2. Periocular basal cell carcinoma results and surgical outcome during a 5-year period in a larger Danish population.
Karlsdóttir SB; Johannessen S; Bjerrum NC; Frydkjær-Olsen U; Blindbæk SL; Møller F; Wellejus C
BMC Ophthalmol; 2022 Jun; 22(1):282. PubMed ID: 35761210
[TBL] [Abstract][Full Text] [Related]
3. Histological subtypes of periocular basal cell carcinoma.
Wu A; Sun MT; Huilgol SC; Madge S; Selva D
Clin Exp Ophthalmol; 2014; 42(7):603-7. PubMed ID: 24533627
[TBL] [Abstract][Full Text] [Related]
4. [Recurrence risk of periocular basal cell carcinoma after histologically controlled excision].
Dethmers A; Löw U; Langenbucher A; Flockerzi F; Bohle RM; Seitz B
Ophthalmologie; 2023 Mar; 120(3):285-293. PubMed ID: 36112203
[TBL] [Abstract][Full Text] [Related]
5. Periocular Basal Cell Carcinoma: 20-Years Experience at a Tertiary Eye Care Center of South India.
Vijay V; Alam MS; Subramanian N; Krishnakumar S; Biswas J; Mukherjee B
Oman J Ophthalmol; 2020; 13(3):129-135. PubMed ID: 33542600
[TBL] [Abstract][Full Text] [Related]
6. Presence of ulceration, but not high risk zone location, correlates with unfavorable histopathological subtype in facial basal cell carcinoma.
Yalcin O; Sezer E; Kabukcuoglu F; Kilic AI; Sari AG; Cerman AA; Altunay IK
Int J Clin Exp Pathol; 2015; 8(11):15448-53. PubMed ID: 26823913
[TBL] [Abstract][Full Text] [Related]
7. Vismodegib as an adjuvant treatment for periorbital basal cell carcinoma: a case report and review of literature.
Jabbehdari S; Veluvolu M; Kornhauser T; Jennings TA; Pemberton JD
Ann Transl Med; 2024 Jun; 12(3):54. PubMed ID: 38911557
[TBL] [Abstract][Full Text] [Related]
8. Staged excision of primary periocular basal cell carcinoma: absence of residual tumour in re-excised specimens: a 10-year series.
McGrath LA; Meeney A; Currie ZI; Mudhar HS; Tan JH
Br J Ophthalmol; 2019 Jul; 103(7):976-979. PubMed ID: 30181140
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of histopathological margin and other recurrence parameters in basal cell carcinoma: A retrospective analysis of 8821 lesions.
Yildizdal S; Kucukguven A; Calis M; Vargel I
J Plast Reconstr Aesthet Surg; 2022 Sep; 75(9):3390-3397. PubMed ID: 35902332
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for recurrence of facial basal cell carcinoma after surgical excision: A follow-up analysis.
Armstrong LTD; Magnusson MR; Guppy MPB
J Plast Reconstr Aesthet Surg; 2017 Dec; 70(12):1738-1745. PubMed ID: 28579037
[TBL] [Abstract][Full Text] [Related]
11. Long-term results after surgical basal cell carcinoma excision in the eyelid region: revisited.
Told R; Reumueller A; Kreminger J; Lackner B; Kuchar A; Schmidt-Erfurth U; Dunavoelgyi R
Wien Klin Wochenschr; 2024 Feb; ():. PubMed ID: 38349412
[TBL] [Abstract][Full Text] [Related]
12. 5 years review of periocular basal cell carcinoma and proposed follow-up protocol.
Ho SF; Brown L; Bamford M; Sampath R; Burns J
Eye (Lond); 2013 Jan; 27(1):78-83. PubMed ID: 23154501
[TBL] [Abstract][Full Text] [Related]
13. Predictors for margin of resection >4 mm in the management of periocular basal cell carcinoma.
Almousa R
Korean J Ophthalmol; 2021 Oct; 35(5):391-396. PubMed ID: 34344136
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of Biopsy in Subtyping Periocular Basal Cell Carcinoma.
Sun MT; Wu A; Huilgol SC; Selva D
Ophthalmic Plast Reconstr Surg; 2015; 31(6):449-51. PubMed ID: 25794023
[TBL] [Abstract][Full Text] [Related]
16. Histological and clinical features of primary and recurrent periocular Basal cell carcinoma.
Ben Simon GJ; Lukovetsky S; Lavinsky F; Rosen N; Rosner M
ISRN Ophthalmol; 2012; 2012():354829. PubMed ID: 24555125
[TBL] [Abstract][Full Text] [Related]
17. Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment.
Shi Y; Jia R; Fan X
Onco Targets Ther; 2017; 10():2483-2489. PubMed ID: 28507440
[TBL] [Abstract][Full Text] [Related]
18. Non-melanoma skin cancer excision with frozen section histology.
Poulsen CB; Stolle LB; Rindom MB
Dan Med J; 2023 Apr; 70(5):. PubMed ID: 37125822
[TBL] [Abstract][Full Text] [Related]
19. Implication of wide surgical excision in minimizing positive margins and consequential secondary excision - a retrospective comparative study involving 106 basal cell carcinoma cases.
Kundnani NR; Tirziu RV; Borza C; Tirziu C; Sharma A; Rosca CI; Baderca F; Paul C; Solovan CS; Blidisel A
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4283-4288. PubMed ID: 34227063
[TBL] [Abstract][Full Text] [Related]
20. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.
Malhotra R; Huilgol SC; Huynh NT; Selva D
Ophthalmology; 2004 Apr; 111(4):631-6. PubMed ID: 15051193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
